Searche

Your search for "regulation" matched 548 page(s).

Showing results 181 to 190.

Regulatory Public Disclosure - Volume 34, Issue

This section provides important updates in the evolving world of the complex writing environment for regulatory medical writers. Medical Writing. 2025;34(2):100–106. https://doi.org/10.56012/qbev3223

Update of the Consolidated Health Economic Evaluation Reporting Standards: CHEERS 2022 - Volume 31, Issue

If economic evaluations are to be used by researchers and healthcare decision makers, they need to be adequately reported. This article discusses the update of the Consolidated Health Economic Evaluation Reporting Standards (CHEERS 2022), the main…

Gained in Translation - Volume 24, Issue

Welcome to my second Gained in Translation editorial! Translation consulting networks are an interesting ‘assisted-translation tool’, which have had a remarkable appeal for professionals in the field since the late 1990s. Newsgroups, online…

Gained in Translation: Science at the multilingual crossroads - Volume 23, Issue

The concept of equivalence in translation has long been hotly debated. Thus, it has been argued that ‘equivalent’ means ‘virtually the same thing’ and that equivalence in translation is therefore an ‘illusion’. Alternatively, equivalence has been…

Value of medical writing: The regulatory writer's perspective - Volume 31, Issue

The American Medical Writers Association formed a working group in 2020 focused on understanding and communicating the value that regulatory medical writers contribute to project teams, companies, and the wider research community. The working…

Gained in Translation - Volume 21, Issue

Science at the multilingual crossroads With Medical Writing's third issue, this seems to be a good time to recall why this journal features a section on multilingual aspects – and why this section is called what it's called. Medical writing,…

Regulatory submissions of non-interventional post-authorisation safety studies - Volume 26, Issue

The post-authorisation safety study (PASS) is a pharmacovigilance activity often required as a post-marketing commitment to establish a safety profile or address specific safety concerns. An imposed PASS must be submitted in common technical…

Regulatory Public Disclosure - Volume 28, Issue

Keeping up with regulatory public disclosure (RPD) globally is a challenge for us all. This regular RPD section of Medical Writing and EMWA’s RPD Special Interest Group (SIG) help you stay ahead of the game through information sharing.

Foreword: Writing for Patients, Foreword from the EMA - Volume 29, Issue

In recent years, regulators across the globe have improved the way they communicate to patients and the general public about their activities and how medicines are regulated.

The use of machine translation and AI in medical translation: pros and cons - Volume 33, Issue

In this article, I provide a retrospective look at the emergence of translation technologies and summarise the pros and cons of the use of neural machine translation and generative AI tools in medical translation. I will examine both the advantages…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: